TFRC and neoplasm: We selected Tf as the tumor targeting ligand because of its specific interactions with Tf receptor (TfR) over-expressed cancer cells and broad applications in receptor-mediated delivery of drug-conjugates 33-34 and tumor imaging 35-36.